Immunogen (IMGN) Shares Up 40%, Following Positive SORAYA Trial Results

November 30, 2021 8:10 AM

Immunogen (NASDAQ: IMGN) shares are ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found